STOCK TITAN

Moelis & Co Form 4 Filings

MC NYSE

Every Form 4 that Moelis & Co (MC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MC filings page.

Rhea-AI Summary

Thorold Barker, a director of Moelis & Co (MC), received 2025 Annual Restricted Stock Units totaling 1,614.38 units on 09/18/2025. The Form 4 shows these RSUs were issued as dividend equivalents on underlying Annual RSUs granted July 14, 2025, and will vest concurrently with those underlying awards. Each RSU represents the right to receive one share of Class A common stock. The reported grant lists a price of $13.38 and the filing was signed by an attorney-in-fact on 09/19/2025.

Rhea-AI Summary

Christopher Callesano, Chief Financial Officer of Moelis & Co (MC), reported issuances of dividend-equivalent Restricted Stock Units (RSUs) on 09/18/2025. The Form 4 shows dividend-equivalent Incentive RSUs credited for multiple grant vintages: 2020 (3.65 RSUs; 439.7 shares held after), 2021 (6.3 RSUs; 760.36), 2022 (14.9 RSUs; 1,797.35), 2023 (13.65 RSUs; 1,646.33), and 2024 (13.62 RSUs; 1,642.48). Each RSU represents the right to receive either one share of Class A common stock or a cash amount equal to the fair market value on settlement. The entries are reported as acquisitions (code A) with a reported price of $0, and the dividend-equivalent RSUs vest concurrently with the underlying unvested Incentive RSUs.

Rhea-AI Summary

Moelis & Co (MC) director Louise Mirrer reported receipt of restricted stock units (RSUs) on 09/18/2025. The Form 4 lists three non-derivative RSU entries: 1,253.3, 38.76, and 1,695.05 RSUs, each identified as dividend-equivalent RSUs that will vest concurrently with their underlying annual RSUs. The filing was executed by an attorney-in-fact and signed 09/19/2025. No option exercises or derivative transactions are reported. The Form 4 reflects additional equity compensation issued to a director rather than cash transactions or disposals.

Rhea-AI Summary

Moelis & Co (MC) director Laila Worrell reported acquisitions of restricted stock units on 09/18/2025. The Form 4 shows three separate awards of dividend-equivalent RSUs tied to previously granted awards: 2024 Annual RSUs, 2025 Annual RSUs and 2025 Elective RSUs. Each RSU represents the right to receive one share of Class A common stock and the dividend-equivalent RSUs will vest concurrently with the underlying RSUs. The Form is signed by an attorney-in-fact on 09/19/2025.

Rhea-AI Summary

Moelis & Company (MC) insider report: Katherine Pilcher Ciafone, listed as Chief Operating Officer, received dividend-equivalent Restricted Stock Units (RSUs) that settle into Class A common stock or cash at the company's option. Transactions dated 09/18/2025 show additions to three incentive RSU grants: 2020 Incentive RSUs (1,465.68 underlying shares), 2021 Incentive RSUs (2,784.01 underlying shares) and 2022 Incentive RSUs (5,941.42 underlying shares). Each grant is reported with a $0 acquisition price, reflecting issuance as dividend equivalents that will vest concurrently with the underlying unvested awards. The form is signed by an attorney-in-fact on 09/19/2025.